top of page

August 2019 // Funding

Updated: Nov 6, 2020

Synendos receives a co-fund by the European Union as part of the SME Instrument phase 1 (Horizon2020) to contribute to the translation of our preclinical programme into clinical development.

Recent Posts

See All

Synendos Series A Extension Synendos Therapeutics is thrilled to announce an extension to the Series A financing with the addition of Ysios Capital to its syndicate of European investors. Ysios Capita

Synendos and Prof. Jürg Gertsch received an Innosuisse Innovation Grant (total value of CHF 950’000).

bottom of page